Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.CNBC • 05/01/24
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationBusiness Wire • 05/01/24
Stock Market Crash Warning: Don't Get Caught Holding These 3 Healthcare StocksInvestorPlace • 04/30/24
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiationsCNBC • 04/29/24
These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 YearsThe Motley Fool • 04/24/24